论文部分内容阅读
集团简介红日药业集团红日药业集团创建于1996年,是一家横跨现代中药制剂、中药配方颗粒、化学合成药、生物技术药、医疗器械、互联网医疗等诸多领域.融投资、研发、生产、资本于一体的高科技医药健康产业集团。2009年,红日药业作为全国首批、天津首家企业在深圳证券交易所创业板上市(股票代码300026).凭借强劲实力,市值迅速攀升,达220亿元。因业绩突出,集团连续三年荣登《福布斯》中国潜力企业榜,获2014年度最受投资者尊重的上市公司百强奖、201.4年度金牛最佳创业成长公司、201.4年度金牛上市公司百强、中国医药制造业100强企业、中国医药上市公司20强、2014年度中国医药社会责任优秀奖等众多殊荣。
Group Profile Red Sun Pharmaceutical Group Red Sun Pharmaceutical Group was founded in 1996, is a modern medicine across the modern formulations, Chinese medicine particles, chemical synthesis drugs, biotechnology medicine, medical equipment, Internet and many other areas of medical and financial investment, research and development , Production, capital in one of the high-tech medical and health industry group. In 2009, Hong Ri Pharmaceutical was the first batch in the country and Tianjin’s first company was listed on the GEM of Shenzhen Stock Exchange (stock code: 300026). With its strong strength, its market capitalization rapidly climbed to 22 billion yuan. Due to outstanding performance, the Group topped Forbes China Potential Enterprise List for three consecutive years. It was named one of the Top 100 Listed Companies Most Respected Investors in 2014, Taurus Best Entrepreneurship Growth Company of 201.4, Top 100 Listed Taurus Enterprises in 201 4, China Top 100 Pharmaceutical Manufacturing Companies, China Pharmaceutical Listed Companies 20, 2014 China Medical Social Responsibility Excellence Award and many other awards.